Literature DB >> 2881755

The series-compartment model for hepatic elimination.

M R Gray, Y K Tam.   

Abstract

An empirical model is presented for hepatic elimination of substrates which treats the liver as a series of compartments. The number of compartments serves as an adjustable parameter and determines the effect of changes in blood flow on elimination. By allowing variable dependence of clearance on blood flow, the model serves as a bridge between the extreme cases of venous equilibrium (the "well-stirred" model) and the "parallel-tube" model. The adjustable parameter in the model can be determined by measuring the clearance at different rates of blood flow, or at different extents of binding of the substrate to blood components. Examples are given for steady state elimination of several different substrates with linear and nonlinear elimination kinetics.

Mesh:

Year:  1987        PMID: 2881755

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  7 in total

1.  A compartmental model of hepatic disposition kinetics: 1. Model development and application to linear kinetics.

Authors:  Yuri G Anissimov; Michael S Roberts
Journal:  J Pharmacokinet Pharmacodyn       Date:  2002-04       Impact factor: 2.745

2.  Axial tissue diffusion can account for the disparity between current models of hepatic elimination for lipophilic drugs.

Authors:  L P Rivory; M S Roberts; S M Pond
Journal:  J Pharmacokinet Biopharm       Date:  1992-02

3.  Application of the dispersion model for description of the outflow dilution profiles of noneliminated reference indicators in rat liver perfusion studies.

Authors:  A J Schwab; W Geng; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1998-04

Review 4.  Clinical significance of pharmacokinetic models of hepatic elimination.

Authors:  D J Morgan; R A Smallwood
Journal:  Clin Pharmacokinet       Date:  1990-01       Impact factor: 6.447

5.  Metabolite mean transit times in the liver as predicted by various models of hepatic elimination.

Authors:  G D Mellick; Y G Anissimov; A J Bracken; M S Roberts
Journal:  J Pharmacokinet Biopharm       Date:  1997-08

Review 6.  Individual variation in first-pass metabolism.

Authors:  Y K Tam
Journal:  Clin Pharmacokinet       Date:  1993-10       Impact factor: 6.447

7.  Pharmacokinetic modeling of the sinusoidal efflux of anionic ligands from the isolated perfused rat liver: the influence of albumin.

Authors:  J H Proost; H M Nijssen; C B Strating; D K Meijer; G M Groothuis
Journal:  J Pharmacokinet Biopharm       Date:  1993-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.